BioSpace News Archive

RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) (“the Company” or “RegeneRx”), a clinical-stage drug development company focused on tissue protection, repair and regeneration, is updating the status of the U.S. phase 3 dry eye clinical trial (ARISE-3) and the U.S. trial in patients with epidermolysis bullosa (EB) based on a letter to stockholders issued today by its partner, GtreeBNT.

A fully integrated biopharmaceutical company – Uni-Bio Science Group Limited (the “Company”, together with its subsidiaries, the “Group, Stock code: 0690.HK), is pleased to announce that the bioequivalence study (“BE Study”) and its clinical materials on Acarbose tablets jointly developed by Beijing Genetech Pharmaceutical Co.

Tips for improving your oral health in 2019

Federal Street Acquisition Corp. (NASDAQ: FSACU, FSAC, FSACW) (“FSAC”), a special-purpose acquisition company sponsored by an affiliate of Thomas H. Lee Partners, L.P. (“THL”), and Agiliti Holdco, Inc., the holding company of Agiliti Health, Inc. (“Agiliti Health”), a leading, nationwide provider of healthcare technology management and service solutions and a portfolio company of Irving Place Capital Management, L.P., announced today that they have completed their business combination.

“As a man, I do not want to contract anything from a home or public bathroom so I always hold my genitals to keep them away from the rim of the toilet,” said an inventor from Cincinnati, Ohio. “This inspired me to develop a means to protect men from germs and diseases when seated on the toilet.”

Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that Co-Chief Operating Officer Alex Gourlay and Executive Vice President and Global Chief Financial Officer James Kehoe will participate in a fireside chat at the 37th Annual J.P. Morgan Healthcare Conference, Monday, January 7 at 3:00 p.m. Pacific time (6:00 p.m. Eastern time).

Candel Therapeutics, a clinical-stage biotechnology company developing novel cancer immunotherapy therapeutics, today announced that Dr. Estuardo Aguilar-Cordova, Chief Executive Officer, will present at the 37th Annual J.P. Morgan Healthcare Conference on Thursday, January 10, 2019 at 7:30 a.m. Pacific Time.

Programming at 2019 J.P. Morgan Healthcare Conference January 7 - 9th will help health industry organizations identify game-changing investment and acquisition opportunities and meet emerging challenges head on

PerkinElmer, Inc. announced that on Thursday, January 31, 2019, after market close, the Company will release fourth quarter 2018 results

Select Medical Holdings Corporation (“Select Medical”) (NYSE: SEM), today announced its business outlook for calendar year 2019.